Hsu, Hsiang-Ting
Cheng, Hui-Chen
Hou, Tsung-Wei
Tzeng, Yi-Shiang
Fuh, Jong-Ling
Chen, Shih-Pin
Chen, Wei-Ta
Lee, Wei-Ju
Pai, Yen-Wei
Lee, Yi-Chung
Lirng, Jiing-Feng
Wang, Shuu-Jiun
Wang, Yen-Feng
Funding for this research was provided by:
National Science and Technology Council (110-2321-B-010-005, 111-2321-B-A49-004, 111-2314-B-075 -086 -MY3, 111-2321-B-A49-011, and 112-2321-B-075-007, 109-2314-B-075 -054 and 110-2314-B-075 -041 -MY3)
Ministry of Health and Welfare (MOHW112-TDU-B-211-144001)
Taipei Veterans General Hospital (V108C-092, V109C-096, V110C-111, V111C-161, V112C-078, V113C-123, and V112D67-003-MY3)
Article History
Received: 22 July 2024
Accepted: 29 August 2024
First Online: 4 September 2024
Declarations
:
: The study protocols were approved by the Institutional Review Board of Taipei Veterans General Hospital (TVGH IRB No. 2022-04-005AC, and TCVGH IRB No. CE23493C).
: Not applicable.
: W.T.C. has received honoraria as a speaker from Allergan/AbbVie, Hava Bio-Pharma, Orient EuroPharma, Pfizer, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. S.J.W. has received personal fees as an advisor or speaker from AbbVie, Orient EuroPharma, Pfizer, and Percept; and has been the PI in trials sponsored by Allergan/AbbVie, Lundbeck, Novartis, Pfizer, and Orient EuroPharma. He has received research grants from the Taiwan National Science and Technology Council and Taipei Veterans General Hospital. Y.F.W. has received personal fees as an advisor or a speaker from Allergan/AbbVie, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Eli Lilly, Hava Bio-Pharma, Lundbeck, Novartis, Orient EuroPharma, Pfizer, Sanofi, Teva, UCB, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. H.T.H, H.C.C., T.W.H., Y.S.T., J.L.F., S.P.C., W.J.L., Y.W.P., Y.C.L., and J.F.L. reported no relevant disclosure.